Standardization of NAT for Blood-Borne Pathogens

Transfusion Medicine and Hemotherapy

Volumn 42, Issue 4, 2015, Pages 211-218

  Baylis, Sally A ^a   Chudy, Michael ^a   Nubling, C Micha ^a,b  

^a PAUL EHRLICH INSTITUT   (Germany)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

International unit; IVD; NAT; Standardization; WHO standards

Indexed keywords

BLOODBORNE BACTERIUM; CALIBRATION; GENE AMPLIFICATION; HUMAN; INTERNATIONAL STANDARD UNIT; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID AMPLIFICATION TECHNOLOGY; QUALITY CONTROL; REVIEW; STANDARD; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

EID: 84939558175     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000435872     Document Type: Review

References (52)

1. Paul-Ehrlich-Institut: Stufenplan: Bekanntmachung über die Ergebnisse des Stufenplanverfahrens zur Verminderung des Risikos von Hepatitis B-, Hepatitis Cund HIV Infektionen bei Empfängern von Erythrozytenkonzentraten (Bundesanzeiger Nr. 63 vom 04.04.1997, S. 4477). Bundesanzeiger 1989; 53: 3835.
2. Albertia A, Caporaso N: HBV therapy: Guidelines and open issues. Dig Liver Dis 2011; 43(suppl 1):S57-63.
3. Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN: Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722-724.
4. Damen M, Cuypers HT, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH, Niesters HG, Lelie PN: International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods 1996; 58: 175-185.
5. Saldanha J, Minor P: Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR. Vox Sang 1996; 703: 148-151.
6. Saldanha J, Lelie N, Heath A: Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group. Vox Sang 1999; 76: 149-158.
7. Bootman JS, Kitchin PA: An international collaborative study to assess a set of reference reagents for HIV-1 PCR. J Virol Methods 1992; 37: 23-41.
8. Bootman JS, Kitchin PA: Reference preparations in the standardisation of HIV-1 PCR-an international collaborative study. J Virol Methods 1994; 49: 1-8.
9. Heath AB, Hughes P, Holmes H: An international collaborative study on the detection of an HIV-1 genotype B field isolate by nucleic acid amplification techniques. J Virol Methods 1999; 78: 21-34.
10. Holmes H, Davis C, Heath A, Hewlett I, Lelie N: An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Methods 2001; 92: 141-150.
11. Baylis SA, Blümel J, Mizusawa S, Matsubayashi K, Sakata H, Okada Y, Nübling CM, Hanschmann KM; HEV Collaborative Study Group: World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Emerg Infect Dis 2013; 19: 729-735.
12. Holmes H, Berry N, Heath A, Morris C: Preparation and evaluation of the 1st international standard for the quantitation of HIV-2 RNA in plasma. J Virol Methods 2001; 175: 246-252.
13. Padley DJ, Heath AB, Sutherland C, Chiodini PL, Baylis SA; Collaborative Study Group: Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays. Malar J 2008; 7: 139.
14. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A; WHO Collaborative Study Group: An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001; 80: 63-71.
15. Saldanha J, Lelie N, Yu MW, Heath A; B19 Collaborative Study Group: Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 2002; 82: 24-31.
16. Saldanha J, Heath A, Lelie N, Pisani G, Yu MY; Collaborative Study Group: A World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays. Vox Sang 2005; 89: 52-58.
17. World Health Organization: Collaborative Study to Evaluate the Proposed 1st WHO International Standard for Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification (NAT)-Based Assays. WHO/BS/10.2138. 2010. http://whqlibdoc.who.int/hq/2010/WHO-BS-10.2138-eng.pdf (last accessed June 15, 2015).
18. World Health Organization: WHO International Biological Reference Preparations. Blood products and related substances: Blood safety. www.who.int/bloodproducts/catalogue/Safe2015.pdf (last accessed June 15, 2015).
19. Baylis SA, Ma L, Padley DJ, Heath AB, Yu MW; Collaborative Study Group: Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays. Vox Sang 2012; 102: 204-211.
20. Baylis SA: Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: a meeting summary. Vox Sang 2008; 94: 74-80.
21. European Commission: Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Official Journal of the European Union 1998;L 331/1-L331/37.
22. European Commission: Commission Decision of 3 February 2009 amending Decision 2002/364/EC on common technical specifications for in vitro-diagnostic medical devices (2009/108/EC). Official Journal of the European Union 2009;L39/34-L39/49.
23. Davis C, Berry N, Heath A, Holmes H: An international collaborative study to establish a replacement World Health Organization International Standard for human immunodeficiency virus 1 RNA nucleic acid assays. Vox Sang 2008; 95: 218-225.
24. World Health Organization: Recommendations for the preparation, characterization and establishment of international and other biological reference standards (revised 2004). WHO Technical Report Series 2006; 932: 73-131. www.who.int/immunization-standards/vaccine-reference-preparations/TRS932Annex%202-Inter%20-biol%20ef%20standards%20rev2004.pdf (last accessed June 15, 2015).
25. Baylis SA, Hanschmann KM, Blümel J, Nübling CM; HEV Collaborative Study Group: Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011; 49: 1234-1239.
26. Miller WG, Myers GL, Rej R: Why commutability matters. Clin Chem 2006; 52: 553-554.
27. Vesper HW, Miller WG, Myers GL: Reference materials and commutability. Clin Biochem Rev 2007; 28: 139-147.
28. Hayden RT, Shahbazian MD, Valsamakis A, Boonyaratanakornkit J, Cook L, Pang XL, Preiksaitis JK, Schönbrunner ER, Caliendo AM: Multicenter evaluation of a commercial cytomegalovirus quantitative standard: effects of commutability on interlaboratory concordance. J Clin Microbiol. 2013; 51: 3811-3817.
29. World Health Organization: WHO Consultation on Commutability of WHO Biological Reference Preparations for In Vitro Detection of Infectious Markers. WHO Headquarters, Geneva, 18-19 April, 2013. www. who.int/bloodproducts/norms/BS-2230-Addendum1-Commutability.pdf?ua=1 (last accessed June 15, 2015).
30. Baylis SA, Heath AB, Chudy M, Pisani G, Klotz A, Kerby S, Gerlich W: An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays. Vox Sang 2008; 94: 358-362.
31. Baylis SA, Chudy M, Blümel J, Pisani G, Candotti D, José M, Heath AB: Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays. Vox Sang 2010; 98: 441-446.
32. Baylis SA, Heath AB; Collaborative Study Group: World Health Organization collaborative study to calibrate the 3rd International Standard for Hepatitis C virus RNA nucleic acid amplification technology (NAT)-based assays. Vox Sang 2011; 100: 409-417.
33. Saldanha J, Heath A, Aberham C, Albrecht J, Gentili G, Gessner M, Pisani G: World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays. Vox Sang 2005; 88: 202-204.
34. Fryer JF, Heath AB, Wilkinson DE, Minor PD: Collaborative Study to Evaluate the Proposed 4th WHO International Standard for Hepatitis C Virus (HCV) for Nucleic Acid Amplification Technology (NAT)-Based Assays. 2011;WHO/BS/2011.2173.
35. Holmes H, Davis C, Heath A: Development of the 1st International Reference Panel for HIV-1 RNA genotypes for use in nucleic acid-based techniques. J Virol Methods 2008; 154: 86-91.
36. Chudy M, Hanschmann KM, Kress J, Nick S, Campos R, Wend U, Gerlich W, Nübling CM: First WHO International Reference Panel containing hepatitis B virus genotypes A-G for assays of the viral DNA. J Clin Virol 2012; 55: 303-309.
37. Nübling CM, Daas A, Buchheit KH: Collaborative study for establishment of a European Pharmacopoei Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique. Pharmeuropa Bio 2004; 2003: 27-34.
38. Saldanha J, Heath A, Lelie N, Pisani G, Nübling M, Yu M: Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group. Vox Sang 2000; 78: 217-224.
39. Davis C, Heath A, Best S, Hewlett I, Lelie N, Schuurman R, Holmes H: Calibration of HIV-1 working reagents for nucleic acid amplification techniques against the 1st international standard for HIV-1 RNA. J Virol Methods 2003; 107: 37-44.
40. Saldanha J, Minor P: Collaborative study to assess the suitability of a proposed working reagent for human parvovirus B19 DNA detection in plasma pools by gene amplification techniques. B19 Collaborative Study Group. Vox Sang 1997; 734: 207-211.
41. International Organization for Standardization: ISO 17511: 2003(en): In vitro Diagnostic Medical Devices-Measurement of quantities in Biological Samples-Metrological traceability of Values assigned to Calibrators and Control Materials. www.iso.org/obp/ui/#iso:std: iso:17511:ed-1:v1:en (last accessed June 15, 2015).
42. Madej RM, Davis J, Holden MJ, Kwang S, Labourier E, Schneider GJ: International standards and reference materials for quantitative molecular infectious disease testing. JMol Diagn 2010; 12: 133-143.
43. Chudy M, Hewlett I, Saldanha J, Bianco C, Conrad AJ, Gierman T, Heldebrant C, Rautmann GG, Roth WK, Stramer S, Weimer T, Whitaker B, Zerlauth G; NAT Task Force Group: Technical considerations for the performance of Nucleic acid Amplification Technology (NAT). Biologicals 2003; 31: 153-159.
44. Gentili G, Pisani G, Saldanha J, Cristiano K, Wirz M, Bisso GM, Mele C; EQA Participants: High proficiency in detecting the six major hepatitis C virus genotypes of laboratories involved in testing plasma by nucleic acid amplification technology. Vox Sang 2003; 85: 114-116.
45. Best SJ, Gust AP, Johnson EIM, McGavin CH, Dax E: Quality of human immunodeficiency virus viral load testing in Australia. J Clin Microbiol 2000; 38: 4015-4020.
46. Schirm J, van Loon AM, Valetnine-Thon E, Klapper P, Reid J, Cleator G: External quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology. J Clin Microbiol 2002; 40: 2973-2980.
47. Fryer JF, Heath AB, Morris CL, Collaborative Study Group: Collaborative Study to Evaluate the Proposed 2nd WHO International Standard for Hepatitis A Virus (HAV) for Nucleic Acid Amplification Technology (NAT)-Based Assays. 2013;WHO/BS/2013.2225.
48. Fryer JF, Heath AB, Wilkinson DE: Collaborative Study to Evaluate the Proposed 3rd WHO International Standard for Hepatitis B Virus (HBV) for Nucleic Acid Amplification Technology (NAT)-Based Assays. 2011;WHO/BS/2011.2170
49. Morris CL, Heath AB: International Collaborative Study to Establish the 3rd WHO International Standard for HIV-1 NAT Assays. 2011;WHO/BS/2011.2178
50. FryerJF, Heath AB, Morris CL, Collaborative Study Group: Collaborative Study to Evaluate the Proposed 3rd WHO International Standard for Parvovirus B19 (B19V) for Nucleic Acid Amplification Technology (NAT)-Based Assays. 2013;WHO/BS/2013.2224
51. Morris CL, Wigglesworth E, Heath AB: Report on an International Collaborative Study to Establish the 2nd WHO International Subtype Reference panel for HIV-1 NAT Assays. 2012;WHO/BS/2012.2209
52. Morris CL, Wigglesworth E, Heath AB: Report on an International Collaborative Study to Establish the 1st WHO International Reference Panel for HIV-1 Circulating Recombinant Forms for NAT Assays. 2013; WHO/BS/2013.2226.